JPH07503462A - カルシウムチャンネル拮抗薬としてのアザビシクロ化合物 - Google Patents

カルシウムチャンネル拮抗薬としてのアザビシクロ化合物

Info

Publication number
JPH07503462A
JPH07503462A JP5513048A JP51304893A JPH07503462A JP H07503462 A JPH07503462 A JP H07503462A JP 5513048 A JP5513048 A JP 5513048A JP 51304893 A JP51304893 A JP 51304893A JP H07503462 A JPH07503462 A JP H07503462A
Authority
JP
Japan
Prior art keywords
formula
compound
azabicyclo
heptane
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5513048A
Other languages
English (en)
Japanese (ja)
Inventor
オーレック，バリー・シドニー
ブラウン，トーマス・ヘンリー
クーパー，デイビッド・グウィン
Original Assignee
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー filed Critical スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー
Publication of JPH07503462A publication Critical patent/JPH07503462A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
JP5513048A 1992-01-28 1993-01-27 カルシウムチャンネル拮抗薬としてのアザビシクロ化合物 Pending JPH07503462A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929201751A GB9201751D0 (en) 1992-01-28 1992-01-28 Compounds
GB9201751.6 1992-01-28
PCT/GB1993/000174 WO1993015080A1 (en) 1992-01-28 1993-01-27 Azabicyclo compounds as calcium channel antagonists

Publications (1)

Publication Number Publication Date
JPH07503462A true JPH07503462A (ja) 1995-04-13

Family

ID=10709351

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5513048A Pending JPH07503462A (ja) 1992-01-28 1993-01-27 カルシウムチャンネル拮抗薬としてのアザビシクロ化合物

Country Status (9)

Country Link
EP (1) EP0625981A1 (de)
JP (1) JPH07503462A (de)
KR (1) KR950700305A (de)
AU (1) AU3364593A (de)
CA (1) CA2128536A1 (de)
GB (1) GB9201751D0 (de)
MX (1) MX9300406A (de)
WO (1) WO1993015080A1 (de)
ZA (1) ZA93549B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9314973D0 (en) * 1993-07-20 1993-09-01 Smithkline Beecham Plc Medicaments
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
AU1600599A (en) 1998-02-27 1999-09-15 Warner-Lambert Company Heterocyclic substituted aniline calcium channel blockers
US6166052A (en) * 1998-03-11 2000-12-26 Warner-Lambert Company Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers
CA2441896A1 (en) 2000-12-22 2002-07-04 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
ES2203327B1 (es) 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
ES2204295B1 (es) 2002-07-02 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de quinuclidina-amida.
WO2009046025A1 (en) 2007-10-01 2009-04-09 Comentis, Inc. Quinuclidin-4-ylmethyl 1h-indole-3-carboxylate derivatives as alpha 7 nicotinic acetylcholine receptor ligands for the treatment of alzheimer's disease
WO2016007630A1 (en) 2014-07-11 2016-01-14 Alpharmagen, Llc Quinuclidine compounds for modulating alpha7 -nicotinic acetylcholine receptor activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1250534A (de) * 1969-03-03 1971-10-20
GB9005737D0 (en) * 1990-03-14 1990-05-09 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
KR950700305A (ko) 1995-01-16
CA2128536A1 (en) 1993-08-05
AU3364593A (en) 1993-09-01
WO1993015080A1 (en) 1993-08-05
EP0625981A1 (de) 1994-11-30
ZA93549B (en) 1994-09-22
GB9201751D0 (en) 1992-03-11
MX9300406A (es) 1994-07-29

Similar Documents

Publication Publication Date Title
JPH07503463A (ja) カルシウムチャンネル拮抗薬としてのアザビシクロ化合物
JPH07503461A (ja) カルシウムチャンネル拮抗薬としての化合物
JPH06506467A (ja) 多環式三級アミンポリ芳香族スクアレンシンセターゼインヒビター
JPS61260063A (ja) フエニルアルカノ−ル誘導体
JPH08504419A (ja) カルシウムチャンネル拮抗薬としてのアリールオキシアルキル置換環状アミンの使用および新規フェニルオキシアルキルピペリジン誘導体
JPH06500092A (ja) ３―置換ピペリジン誘導体
JPH07503462A (ja) カルシウムチャンネル拮抗薬としてのアザビシクロ化合物
EP0589971A1 (de) 3-substituierte pyrrolidin-derivate als calciumantagonisten
JP2000503308A (ja) キノリン―２―（１ｈ）―オン類
JPH04234386A (ja) カルボスチリル誘導体
JPH0747585B2 (ja) イソオキサゾール誘導体
JP2632877B2 (ja) 置換１ｈ−イミダゾール化合物
IE902750A1 (en) Coumarin derivatives, their preparation and their use in the¹treatment of cerebrovascular disorders
EP0351255A2 (de) 2-[(4-Piperidinyl)methyl]-1,2,3,4-tetrahydroisochinolin-Derivate, ihre Herstellung und ihre therapeutische Verwendung
JPH089580B2 (ja) アミノアルコ−ル、その製造法およびその用途
JPH09500383A (ja) カルシウムチャネル拮抗剤活性を有するキノリジジン
US20020016467A1 (en) Novel 4-diphenylmethyl piperdine derivatives
FR2753970A1 (fr) Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
HU187480B (en) Process for producing 1-bracket-4-quinolyl-bracket closed-2-bracket-4-piperidyl-bracket closed-ethanol and 1-bracket-4-quinolyl-bracket closed-3-bracket-4-piperidiyl-bracket closed-propanol and pharmaceutival compositions containing them as active agents
JPH09504014A (ja) カルシウムチャネル拮抗薬としてのアミン誘導体類
WO1994002473A1 (fr) Derives de la n-cycloalkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant
JPS5935387B2 (ja) ３−アミノ−２−ヒドロキシプロパンのジ−置換フエノ−ルエ−テル類、その製法ならびに医薬用途
HU192501B (en) Process for producing /2-methyl-propoxy/-methyl-n-phenyl-n-/phenyl-methyl/-1-pyrrolidin-ethanamine
US4267331A (en) Process for the production of 2-substituted pyrido[4,3-b]-indoles
JPH10500967A (ja) カルシウムチャンネルアンタゴニストとしてのフェノキシアルキル置換ピペリジン、ピロリジン、モルホリンおよびチオモルホリン